Insights

Acquisition Legacy Stemcentrx was acquired by AbbVie for 5.8B in 2016, indicating a strong exit history and potential for collaboration with large pharma looking to leverage cancer stem cell platforms and ADC expertise.

Pipeline Focus The company concentrates on cancer stem cell targeting and antibody drug conjugates, presenting opportunities to partner on ADC development, target validation, and translational assets in solid tumors.

Clinical Momentum With GMP manufacturing capabilities and a move from discovery to clinical trials, there is a sellable value in contract research, process development, and early-phase manufacturing services for oncology programs.

Strategic Funding Significant funding and a high revenue range suggest potential for co-development, milestone-driven deals, or strategic licensing with larger biotechs seeking oncology innovation and scalable manufacturing.

SV Culture South San Francisco location and a startup-like, collaborative culture align with engagement for collaboration in core oncology biology, enabling joint ventures, co-lab programs, or academic-industry partnerships.

Similar companies to Stemcentrx, Inc.

Stemcentrx, Inc. Tech Stack

Stemcentrx, Inc. uses 1 technology products and services including Apache, and more. Explore Stemcentrx, Inc.'s tech stack below.

  • Apache
    Web Servers

Stemcentrx, Inc.'s Email Address Formats

Stemcentrx, Inc. uses at least 2 email formats:
Stemcentrx, Inc. Email FormatsExamplePercentage
First.Last@stemcentrx.comJohn.Doe@stemcentrx.com
99%
F.Last@stemcentrx.comJ.Doe@stemcentrx.com
1%

Frequently Asked Questions

What is Stemcentrx, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Stemcentrx, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Stemcentrx, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Stemcentrx, Inc.'s official website is stemcentrx.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Stemcentrx, Inc. generate?

Minus sign iconPlus sign icon
As of October 2026, Stemcentrx, Inc.'s annual revenue is estimated to be $10M - $25M.

What is Stemcentrx, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Stemcentrx, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Stemcentrx, Inc. have currently?

Minus sign iconPlus sign icon
As of October 2026, Stemcentrx, Inc. has approximately 6 employees across 2 continents, including North America and Europe. Key team members include Manager Statistics: S. E., Project Manager: V. D. and Associate Scientist Ii: A. T. Explore Stemcentrx, Inc.'s employee directory with LeadIQ.

What industry does Stemcentrx, Inc. belong to?

Minus sign iconPlus sign icon
Stemcentrx, Inc. operates in the Biotechnology Research industry.

What technology does Stemcentrx, Inc. use?

Minus sign iconPlus sign icon
Stemcentrx, Inc.'s tech stack includes Apache.

What is Stemcentrx, Inc.'s email format?

Minus sign iconPlus sign icon
Stemcentrx, Inc.'s email format typically follows the pattern of First.Last@stemcentrx.com. Find more Stemcentrx, Inc. email formats with LeadIQ.

How much funding has Stemcentrx, Inc. raised to date?

Minus sign iconPlus sign icon
As of October 2026, Stemcentrx, Inc. has raised $516M in funding. The last funding round occurred on Sep 09, 2015 for $250M.

When was Stemcentrx, Inc. founded?

Minus sign iconPlus sign icon
Stemcentrx, Inc. was founded in 2008.
Stemcentrx, Inc. logo

Stemcentrx, Inc.

Biotechnology ResearchCalifornia, United States2-10 Employees

Stemcentrx, Inc. is a biotechnology research company located in South San Francisco, California. Founded in 2008, it integrates laboratory discovery with GMP manufacturing to accelerate moving from target discovery to clinical testing. The company's work centers on cancers by identifying cancer stem cells, uncovering novel targets, and designing and producing antibodies and antibody-drug conjugates. This approach spans early research through clinical investigation, with laboratories and manufacturing facilities described as state-of-the-art. The culture is portrayed as focused and collaborative, echoing the startup environment of the region.

Its stated mission is to develop therapies that cure or substantially improve survival for cancer patients, reflecting a focus on strategies aimed at eradicating cancer stem cells that initiate and sustain tumors. In the biotechnology sector, Stemcentrx positions itself at the intersection of discovery and therapeutic development, aiming to translate scientific insight into patient-accessible treatments. The firm appears to target serious, potentially lethal cancers through its proprietary platforms and manufacturing capabilities. The company employs a small team, reflecting its status as a compact organization within the broader life sciences ecosystem of South San Francisco.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2008
Employees
2-10

Section iconFunding & Financials

  • $516M

    Stemcentrx, Inc. has raised a total of $516M of funding over 4 rounds. Their latest funding round was raised on Sep 09, 2015 in the amount of $250M as a Series G.

  • $10M - $25M

    Stemcentrx, Inc.'s revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.